Blueprint Medicines Corporation (BPMC) Social Stream
Blueprint Medicines Corp (BPMC) Price Targets From Analysts
Use the tables below to see what analysts covering Blueprint Medicines Corp think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 9 | $136 | $84 | $113.222 | $66.56 | 70.11% |
| 2021-11-10 | 9 | $136 | $84 | $114.444 | $66.56 | 71.94% |
| 2021-11-19 | 9 | $136 | $84 | $115.777 | $66.56 | 73.94% |
| 2021-11-29 | 9 | $136 | $84 | $115.555 | $66.56 | 73.61% |
| 2022-01-12 | 9 | $135 | $84 | $113.333 | $66.56 | 70.27% |
| 2022-01-25 | 9 | $135 | $84 | $110.555 | $66.56 | 66.1% |
| 2022-01-31 | 9 | $135 | $84 | $108.444 | $66.56 | 62.93% |
| 2022-02-08 | 9 | $135 | $84 | $104.777 | $66.56 | 57.42% |
| 2022-02-17 | 9 | $133 | $82 | $100.625 | $66.56 | 51.18% |
| 2022-03-01 | 10 | $133 | $71 | $97.333 | $66.56 | 46.23% |
| 2022-03-22 | 10 | $133 | $71 | $97.888 | $66.56 | 47.07% |
The Trend in the Analyst Price Target
Over the past 18 months, BPMC's average price target has gone down $4.11.
Over the past 48 weeks, BPMC's average upside potential has been 31.01%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-22 | 14 | 152 | 81 | 117.620 | 94.40 | 24.6% |
| 2021-07-15 | 13 | 152 | 81 | 119.690 | 81.28 | 47.26% |
| 2021-11-09 | 9 | 136 | 84 | 113.222 | 114.95 | -1.5% |
| 2021-11-29 | 9 | 136 | 84 | 115.555 | 98.28 | 17.58% |
| 2022-02-08 | 9 | 135 | 84 | 104.777 | 80.51 | 30.14% |
BPMC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 5 | 0 | 5 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 26 weeks, BPMC's average broker recommendation rating worsened by 0.14.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Blueprint Medicines Corp's average analyst price target is higher than 908.37% of them.
- In terms of how Blueprint Medicines Corp fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 924.2% of that group.
- Blueprint Medicines Corp's upside potential (average analyst target price relative to current price) is greater than 309.86% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Blueprint Medicines Corp's variance in analysts' estimates is lower than -677.92% of them.
Stocks similar to Blueprint Medicines Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BHVN, BBIO, and AXSM.
Make investment decisions regarding BPMC using the data that counts. Try POWR Ratings for free.